Proteolysis-targeting chimeras mediate the degradation of bromodomain and extra-terminal domain proteins

Yifei Yang1, Zhenwei Wu2, Pan Chen1

  • 1Department of Medicinal Chemistry, China Pharmaceutical University, Tongjia Xiang 24, Nanjing, 210009, PR China.

Future Medicinal Chemistry
|September 7, 2020
PubMed

Insights

Proteolysis-targeting chimeras offer a novel approach to degrade Bromodomain and extra-terminal domain (BET) proteins, addressing limitations of current inhibitors. This technology promises targeted cancer therapy with potentially fewer side effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Bromodomain and extra-terminal domain (BET) proteins regulate gene transcription and are implicated in various cancers.
  • Current pan-BET inhibitors in clinical trials exhibit off-target effects and undesirable side effects.
  • Proteolysis-targeting chimeras (PROTACs) offer a new therapeutic strategy by inducing target protein degradation.

Purpose of the Study:

  • To review advances in the development of BET-targeting proteolysis-targeting chimeras.
  • To highlight the potential of PROTAC technology for cancer treatment.
  • To discuss the advantages of BET degraders over traditional inhibitors.

Main Methods:

  • Review of current literature on BET protein family.
  • Analysis of proteolysis-targeting chimeras technology and its application to BET proteins.
  • Discussion of drug discovery and development strategies for BET degraders.

Main Results:

  • BET protein family is a promising target for cancer therapy.
  • Proteolysis-targeting chimeras technology enables targeted degradation of BET proteins.
  • Heterobifunctional small molecules can induce BET protein ubiquitination and degradation.

Conclusions:

  • BET-targeting proteolysis-targeting chimeras represent a significant advancement in cancer drug discovery.
  • This technology offers a potential solution to the limitations of existing BET inhibitors.
  • Further development of BET degraders holds promise for more effective and safer cancer therapies.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.4K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.1K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.8K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.3K